🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

108 results for “Xin” Clear

  1. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial

  2. sodium iodide

    United Therapeutics Europe Ltd

    Transient Hypothyroxinemia

    approved small molecule completed

    1 trial

  3. Aescin in Horse Chestnut

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Anorectal Disorder

    small molecule active

    1 trial

  4. Botulinum Toxin Type A Injection [Botox]

    The First People's Hospital of Lianyungang

    Rosacea

    small molecule active

    1 trial

  5. Sulfadoxine-pyrimethamine

    United Therapeutics Europe Ltd

    Anaemia

    small molecule completed

    1 trial

  6. Tianqi Pingchan Granule

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Levodopa-Induced Dyskinesia

    small molecule active

    1 trial

  7. Triferdine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Pregnancy Related

    other completed

    1 trial

  8. Yinxingmihuan oral solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Stable Angina

    small molecule completed

    1 trial

  9. botulinum toxin type A

    Ultragenyx UK Limited

    Hyperhidrosis

    small molecule completed

    1 trial

  10. modified Ma Xing Shi Gan Decoction

    Universal Integrated

    Chronic Obstructive Pulmonary Disease

    small molecule active

    1 trial

  11. placebo

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    PCOS- Polycystic Ovary Syndrome

    other active

    1 trial

  12. thyroxine

    The First People's Hospital of Lianyungang

    Hypothyroidism

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources